InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the detailed record of transactions filed by Davis George Eric, Chief Executive Officer. Director active across 1 companies, notably Biomarin Pharmaceutical INC. In total, 9 filings have been logged. Total volume traded: €1.2m. The latest transaction was filed on 29 April 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€20,259341 shares@ €59.41150.0002% mcap1.5% of flow
Common Stock
SEC:0001567619-22-009494:0·
€93,3162,669 shares@ €34.96290.0008% mcap7.1% of flow
Common Stock
SEC:0001567619-22-009054:0·
€451,1646,129 shares@ €73.61130.0039% mcap34.4% of flow
Common Stock
SEC:0001567619-22-007415:0·
011,040 shares0
Common Stock
SEC:0001567619-22-007181:0·
09,370 shares0
Common Stock
SEC:0001567619-22-006716:0·
€356,3695,518 shares@ €64.58395.3% of flow
Common Stock
SEC:0001567619-21-014415·
€356,3695,518 shares@ €64.5830.0031% mcap27.2% of flow
Common Stock
SEC:0001567619-21-014415:0·
€17,548341 shares@ €51.46084.7% of flow
Common Stock
SEC:0001567619-21-009021·
€17,548341 shares@ €51.46080.0002% mcap1.3% of flow
Common Stock
SEC:0001567619-21-009021:0·
9 of 9 declarations
About Davis George Eric
George Eric Davis serves as Executive Vice President and Chief Legal Officer at BIOMARIN PHARMACEUTICAL INC. He is responsible for managing legal affairs and regulatory compliance for the company. His expertise in business law enables him to effectively advise executives on complex issues.
